Aims & Scope
Epilepsia Open is the new open access journal of the International League Against Epilepsy (ILAE).
The primary aim of Epilepsia Open is to rapidly publish robust high quality results that provide insights in all aspects of epilepsy research.
Specifically, Epilepsia Open will publish peer reviewed, high quality open access articles covering the entire breadth of basic, translational and clinical research in epilepsy.
The spectrum of articles may include all disciplines of life and health sciences, such as public/global health science and societal impact studies.
Epilepsia Open also welcomes submissions of high quality research with confirmatory results, failure-to-confirm studies, and negative results or interesting study protocols for testing new treatments.
Epilepsia Open will publish communications from the ILAE and its Chapters.
A priority is also given to commentaries of issues and concepts that enhance the access and application of basic research findings for clinical scientists and health professionals, and promote a better understanding of clinical challenges for biomedical researchers.
Epilepsia Open is creating a unique forum for the reputable and speedy open access publication of epilepsy research.
We are committed to facilitating and invigorating a robust and successful pipeline for improved human health science in epilepsy.
View Aims & ScopeMetrics & Ranking
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 0.981 |
Quartile
Year | Value |
---|---|
2024 | Q2 |
h-index
Year | Value |
---|---|
2024 | 37 |
Impact Factor
Year | Value |
---|---|
2024 | 2.80 |
Journal Rank
Year | Value |
---|---|
2024 | 4989 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 1087 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Neuroscience, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Plagiarism url
- Preservation url
- Apc url
- License
Plagiarism Policy
This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.
For more details, please refer to our official: Plagiarism Policy.
APC Details
The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine and Neuroscience, ensuring accessibility and quality in research dissemination.
This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,840.00 USD. Learn more.
Explore journals without APCs for alternative publishing options.